Finland· FI-REL-REL7171

Apronin

A aprotinin product, registered in Finland by MEDICA. The same ATC class is registered in 11 of our 19 countries.

ATC B02AB01

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about AproninAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Aprotinin is registered in 11 of 19 countries.

Countries holding a registration under ATC B02AB01 (aprotinin), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
6 of them publish a price we can compare per daily dose

Search aprotinin products by name

Aprotinin · ATC B02AB01

11 / 19 countries

Belgiumprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)

Manufacturer: MEDICA
Country: Finland (FI)
ATC code: B02AB01
ATC class: Aprotinin
Defined daily dose: 500 TSD, E
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for aprotinin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check aprotinin against other medicines How interaction checks work

Aprotinin · interactions on record

6 records

3 severe
3 moderate

Most severe, free to view

Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
TretinoinL01XF01severe
TretinoinL01XX14severe
AlteplaseB01AD02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B02AB01

Aprotinin, as other registers publish it.

All aprotinin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c341cf3b-60f8-4bcc-9a8c-56edb5bb8afa
GET /v1/drugs/c341cf3b-60f8-4bcc-9a8c-56edb5bb8afa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "500",
  "form": "injektioneste",
  "route": null,
  "ddd_unit": "TU",
  "strength": "10000 KIU/ml",
  "atc_label": "aprotiniini",
  "ma_number": "7132",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7171",
  "authorised_at": "1975-09-24"
}

API reference MCP server Plans

See everything about aprotinin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console